Overview
The 2026‑27 Union Budget and the newly signed India‑EU Free Trade Agreement (FTA) together aim to move Ayurveda from a niche practice to a mainstream global health system. The budget raises the AYUSH Ministry’s allocation to ₹4,408 crore, nearly double the amount five years ago, and announces three new All‑India Institutes of Ayurveda. The FTA allows Indian AYUSH practitioners to set up clinics across Europe and paves the way for Indian safety certifications to be recognised there.
Key Developments
- Budget allocation for AYUSH rises to ₹4,408 crore, a 100% increase over the last five years.
- Three new All‑India Institutes of Ayurveda to be set up, mirroring AIIMS in stature.
- National AYUSH Mission funding increased by 66%.
- India‑EU FTA permits Indian AYUSH practitioners to operate in EU countries without sudden policy changes.
- Potential acceptance of Indian safety certifications in the EU, reducing duplicate testing for Ayurvedic products.
Important Facts
The budget’s focus is not merely on expanding facilities but on integrating AYUSH into the national health ecosystem. New AYUSH clinics will be placed inside government hospitals, and modernised dispensaries will receive upgraded laboratory support. The EU‑India FTA, while economic in nature, carries health‑sector provisions that could open a market of over 450 million Europeans for Indian traditional medicines.
Exam Relevance
Understanding this development touches upon several GS papers:
- GS3 – Economy & Health: Budgetary allocations, trade agreements, and their impact on the health sector.
- GS1 – History & Culture: The legacy of traditional Indian systems like Ayurveda and their modern revival.
- GS4 – Ethics & Governance: Balancing heritage with evidence‑based practice, and managing conflicts of interest in research funding.
- GS2 – Polity: Role of the AYUSH Ministry in policy formulation and implementation.
Way Forward
For Ayurveda to succeed globally, India must ensure:
- Rigorous, independently funded clinical trials that meet international standards.
- Transparent publication of both positive and negative results.
- Regulatory harmonisation with EU norms on safety, quality and claim verification.
- Continued public investment in research infrastructure while safeguarding scientific freedom.
Only by coupling traditional knowledge with robust scientific evidence can India protect its heritage, enhance public health, and capture a share of the global wellness market.